Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2011 | 1 |
2019 | 1 |
2021 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Citations
1
article
found by citation matching
Evaluation of salivary metabolomics in oral leukoplakia and oral squamous cell carcinoma.
J Oral Pathol Med. 2019.
PMID: 30714209
Search results
Filters applied: . Clear all
Page 1
Evaluation of salivary metabolomics in oral leukoplakia and oral squamous cell carcinoma.
Sridharan G, Ramani P, Patankar S, Vijayaraghavan R.
Sridharan G, et al.
J Oral Pathol Med. 2019 Apr;48(4):299-306. doi: 10.1111/jop.12835. Epub 2019 Feb 18.
J Oral Pathol Med. 2019.
PMID: 30714209
The aim of the study was to evaluate the clinical utility of salivary metabolites in oral leukoplakia and oral squamous cell carcinoma. ...CONCLUSION: A range of salivary metabolites were significantly altered in o …
The aim of the study was to evaluate the clinical utility of salivary metabolites in oral leukoplakia and ora …
Item in Clipboard
[Study of salivary metabonomics in patients with oral squamous cell carcinoma and leukoplakia].
Xue JY, Zhu XY, Wei CL, Sun P, Zhang H, Deng J.
Xue JY, et al.
Shanghai Kou Qiang Yi Xue. 2021 Apr;30(2):201-205.
Shanghai Kou Qiang Yi Xue. 2021.
PMID: 34109363
Chinese.
PURPOSE: The objective of this study was to detect and analyze the existence of differential metabolites from saliva of patients with oral squamous cell carcinoma(OSCC) by metabonomics method, and to evaluate its application value on clinical di …
PURPOSE: The objective of this study was to detect and analyze the existence of differential metabolites from saliva of patients with ora …
Item in Clipboard
Salivary metabolomics for oral leukoplakia with and without dysplasia.
Kitabatake K, Ishikawa S, Sugimoto M, Enomoto A, Kaneko M, Ota S, Edamatsu K, Yusa K, Hemmi T, Okuyama N, Iino M.
Kitabatake K, et al.
J Stomatol Oral Maxillofac Surg. 2023 Dec;124(6S):101618. doi: 10.1016/j.jormas.2023.101618. Epub 2023 Sep 1.
J Stomatol Oral Maxillofac Surg. 2023.
PMID: 37659754
PURPOSE: Oral leukoplakia (OL) is a common potentially malignant oral disorder. ...This study aimed to identify salivary metabolites that can help differentiate patients with OL from healthy controls (HC) and also dysplastic OL from non-dysplastic OL. …
PURPOSE: Oral leukoplakia (OL) is a common potentially malignant oral disorder. ...This study aimed to identify sali …
Item in Clipboard
Salivary metabolite signatures of oral cancer and leukoplakia.
Wei J, Xie G, Zhou Z, Shi P, Qiu Y, Zheng X, Chen T, Su M, Zhao A, Jia W.
Wei J, et al.
Int J Cancer. 2011 Nov 1;129(9):2207-17. doi: 10.1002/ijc.25881. Epub 2011 Apr 13.
Int J Cancer. 2011.
PMID: 21190195
Free article.
The aim of the current study is to explore salivary metabolomics as a disease diagnostic and stratification tool for oral cancer and leukoplakia and evaluate the potential of salivary metabolome for detection of oral squa …
The aim of the current study is to explore salivary metabolomics as a disease diagnostic and stratification tool for oral …
Item in Clipboard
Cite
Cite